160 related articles for article (PubMed ID: 31977081)
21. Critical Lessons From High-Value Oncology Practices.
Blayney DW; Simon MK; Podtschaske B; Ramsey S; Shyu M; Lindquist C; Milstein A
JAMA Oncol; 2018 Feb; 4(2):164-171. PubMed ID: 29145584
[TBL] [Abstract][Full Text] [Related]
22. Greater Spending Associated with Improved Survival for Some Cancers in OCM-Defined Episodes.
Baumgardner J; Shahabi A; Linthicum M; Vine S; Zacker C; Lakdawalla D
J Manag Care Spec Pharm; 2018 Jun; 24(6):504-513. PubMed ID: 29799330
[TBL] [Abstract][Full Text] [Related]
23. Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations.
Modi PK; Kaufman SR; Borza T; Yan P; Miller DC; Skolarus TA; Hollingsworth JM; Norton EC; Shahinian VB; Hollenbeck BK
Cancer; 2018 Aug; 124(16):3364-3371. PubMed ID: 29905943
[TBL] [Abstract][Full Text] [Related]
24. Geographic differences in Medicare spending.
Kitchell M
N Engl J Med; 2010 Oct; 363(17):1677-8; author reply 1678-9. PubMed ID: 20961255
[No Abstract] [Full Text] [Related]
25. Physician payment outlook for 2012: déjà vu.
Manchikanti L; Singh V; Caraway DL; Benyamin RM; Falco FJ; Hirsch JA
Pain Physician; 2012; 15(1):E27-52. PubMed ID: 22270747
[TBL] [Abstract][Full Text] [Related]
26. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.
McNaughton Collins M; Barry MJ; Zietman A; Albertsen PC; Talcott JA; Walker Corkery E; Elliott DB; Fowler FJ
Urology; 2002 Oct; 60(4):628-33. PubMed ID: 12385923
[TBL] [Abstract][Full Text] [Related]
27. Cancer care spending and use by site of provider-administered chemotherapy in Medicare.
Shooshtari A; Kalidindi Y; Jung J
Am J Manag Care; 2019 Jun; 25(6):296-300. PubMed ID: 31211557
[TBL] [Abstract][Full Text] [Related]
28. Issues in health care: interventional pain management at the crossroads.
Manchikanti L; Hirsch JA
Pain Physician; 2007 Mar; 10(2):261-84. PubMed ID: 17387349
[TBL] [Abstract][Full Text] [Related]
29. Medicare fees and physicians' medicare service volume: beneficiaries treated and services per beneficiary.
Hadley J; Reschovsky JD
Int J Health Care Finance Econ; 2006 Jun; 6(2):131-50. PubMed ID: 16783506
[TBL] [Abstract][Full Text] [Related]
30. The Role of Patient Factors, Cancer Characteristics, and Treatment Patterns in the Cost of Care for Medicare Beneficiaries with Breast Cancer.
Xu X; Herrin J; Soulos PR; Saraf A; Roberts KB; Killelea BK; Wang SY; Long JB; Wang R; Ma X; Gross CP
Health Serv Res; 2016 Feb; 51(1):167-86. PubMed ID: 26119176
[TBL] [Abstract][Full Text] [Related]
31. Differences in spending on provider-administered chemotherapy by site of care in Medicare.
Kalidindi Y; Jung J; Feldman R
Am J Manag Care; 2018 Jul; 24(7):328-333. PubMed ID: 30020752
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Practice Patterns Among Oncologists Participating in the Oncology Care Model.
Walker B; Frytak J; Hayes J; Neubauer M; Robert N; Wilfong L
JAMA Netw Open; 2020 May; 3(5):e205165. PubMed ID: 32421185
[TBL] [Abstract][Full Text] [Related]
33. Predictors of regional Medicare expenditures for otolaryngology physician services.
Smith A; Handorf E; Arjmand E; Lango MN
Laryngoscope; 2017 Jun; 127(6):1312-1317. PubMed ID: 27859299
[TBL] [Abstract][Full Text] [Related]
34. Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death.
Chen CT; Li L; Brooks G; Hassett M; Schrag D
Health Serv Res; 2018 Aug; 53(4):2118-2132. PubMed ID: 28748564
[TBL] [Abstract][Full Text] [Related]
35. The Stability of Physician-Specific Episode Costs for Urologic Cancer Surgery: Implications for Urologists Under the Merit-Based Incentive Program.
Kaye DR; Ye Z; Li J; Herrel LA; Dupree JM; Ellimoottil C; Miller DC
Urology; 2019 Jan; 123():114-119. PubMed ID: 30125647
[TBL] [Abstract][Full Text] [Related]
36. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
Fowler FJ; McNaughton Collins M; Albertsen PC; Zietman A; Elliott DB; Barry MJ
JAMA; 2000 Jun; 283(24):3217-22. PubMed ID: 10866869
[TBL] [Abstract][Full Text] [Related]
37. Association of Pioneer Accountable Care Organizations vs traditional Medicare fee for service with spending, utilization, and patient experience.
Nyweide DJ; Lee W; Cuerdon TT; Pham HH; Cox M; Rajkumar R; Conway PH
JAMA; 2015 Jun; 313(21):2152-61. PubMed ID: 25938875
[TBL] [Abstract][Full Text] [Related]
38. Medicare's New Quality Payment Program Has Started-Are You Ready?
Cardona DM; Black-Schaffer S; Shamanski F; Myles JL
Arch Pathol Lab Med; 2017 Jun; 141(6):741-745. PubMed ID: 28557597
[No Abstract] [Full Text] [Related]
39. Is There Variation in Procedural Utilization for Lumbar Spine Disorders Between a Fee-for-Service and Salaried Healthcare System?
Schoenfeld AJ; Makanji H; Jiang W; Koehlmoos T; Bono CM; Haider AH
Clin Orthop Relat Res; 2017 Dec; 475(12):2838-2844. PubMed ID: 28074438
[TBL] [Abstract][Full Text] [Related]
40. The Relative Importance of Post-Acute Care and Readmissions for Post-Discharge Spending.
Huckfeldt PJ; Mehrotra A; Hussey PS
Health Serv Res; 2016 Oct; 51(5):1919-38. PubMed ID: 26841171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
